Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 473, pseudogene (RNU6-473P) is a **pseudogene** in the human genome that represents a non-functional homolog of the U6 small nuclear RNA (snRNA) gene.[2][4][5] U6 snRNA is an essential and highly conserved component of the spliceosome, which catalyzes pre-mRNA splicing in eukaryotic nuclei[1][3], but pseudogenes like RNU6-473P typically do not produce functional RNA or protein products due to disabling mutations.[2] Pseudogenes can sometimes regulate gene expression via RNA-mediated or epigenetic mechanisms[2], but there is no reported evidence that RNU6-473P has a defined biological or pathological function. RNU6-473P is not a therapeutic target, does not interact with any drugs, and is not used as a biomarker. Its classification as a pseudogene means it should not be confused with the canonical U6 snRNA, which has a critical role in mRNA splicing.[2][4][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 473, pseudogene (RNU6-473P).